TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs7432328
log Bayes Factor = 0.00398872
Chromosome 3   position 162,199,504  (GRCh37) Explore rs7432328 on Ensembl!
Variant rs7432328 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
O42 Premature rupture of membranes
0.000 0.955 0.045
O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems
0.000 0.956 0.044
O32.1 Maternal care for breech presentation
0.000 0.957 0.043
O32 Maternal care for known or suspected malpresentation of foetus
0.000 0.958 0.042
O42.9 Premature rupture of membranes, unspecified
0.000 0.958 0.042
O42.1 Premature rupture of membranes, onset of labour after 24 hours
0.000 0.960 0.040
O34 Maternal care for known or suspected abnormality of pelvic organs
0.000 0.961 0.039
O42.0 Premature rupture of membranes, onset of labour within 24 hours
0.000 0.963 0.037
O43 Placental disorders
0.000 0.963 0.036
O35 Maternal care for known or suspected foetal abnormality and damage
0.000 0.964 0.036
O46 Antepartum haemorrhage, not elsewhere classified
0.000 0.965 0.035
O47 False labour
0.000 0.966 0.034
O34.2 Maternal care due to uterine scar from previous surgery
0.000 0.966 0.034
O40 Polyhydramnios
0.000 0.967 0.033
O32.0 Maternal care for unstable lie
0.000 0.967 0.033
O44 Placenta praevia
0.000 0.968 0.032
O42.2 Premature rupture of membranes, labour delayed by therapy
0.000 0.968 0.032
O30 Multiple gestation
0.000 0.968 0.032
O33 Maternal care for known or suspected disproportion
0.000 0.968 0.031
O31 Complications specific to multiple gestation
0.000 0.968 0.031
O34.7 Maternal care for abnormality of vulva and perineum
0.000 0.969 0.031
O32.2 Maternal care for transverse and oblique lie
0.000 0.969 0.030
O32.9 Maternal care for malpresentation of foetus, unspecified
0.000 0.969 0.030
O32.6 Maternal care for compound presentation
0.000 0.969 0.030
O32.3 Maternal care for face, brow and chin presentation
0.000 0.969 0.030
O43.8 Other placental disorders
0.000 0.970 0.030
O45 Premature separation of placenta [abruptio placentae]
0.000 0.970 0.030
O35.1 Maternal care for (suspected) chromosomal abnormality in foetus
0.000 0.970 0.030
O41 Other disorders of amniotic fluid and membranes
0.000 0.971 0.029
O32.8 Maternal care for other malpresentation of foetus
0.000 0.971 0.029
O47.9 False labour, unspecified
0.000 0.971 0.029
O43.1 Malformation of placenta
0.000 0.972 0.028
O34.1 Maternal care for tumour of corpus uteri
0.000 0.972 0.028
O34.9 Maternal care for abnormality of pelvic organ, unspecified
0.000 0.972 0.028
O34.8 Maternal care for other abnormalities of pelvic organs
0.000 0.972 0.028
O34.6 Maternal care for abnormality of vagina
0.000 0.972 0.028
O34.5 Maternal care for other abnormalities of gravid uterus
0.000 0.972 0.028
O34.4 Maternal care for other abnormalities of cervix
0.000 0.972 0.028
O34.3 Maternal care for cervical incompetence
0.000 0.972 0.028
O34.0 Maternal care for congenital malformation of uterus
0.000 0.972 0.028
O46.9 Antepartum haemorrhage, unspecified
0.000 0.972 0.028
O47.0 False labour before 37 completed weeks of gestation
0.000 0.972 0.028
O32.4 Maternal care for high head at term
0.000 0.972 0.028
O43.9 Placental disorder, unspecified
0.000 0.974 0.026
O43.2 Morbidly adherent placenta
0.000 0.974 0.026
O43.0 Placental transfusion syndromes
0.000 0.974 0.026
O32.5 Maternal care for multiple gestation with malpresentation of one foetus or more
0.000 0.974 0.026
O35.9 Maternal care for (suspected) foetal abnormality and damage, unspecified
0.000 0.974 0.026
O35.8 Maternal care for other (suspected) foetal abnormality and damage
0.000 0.974 0.026
O35.7 Maternal care for (suspected) damage to foetus by other medical procedures
0.000 0.974 0.026
O35.6 Maternal care for (suspected) damage to foetus by radiation
0.000 0.974 0.026
O35.5 Maternal care for (suspected) damage to foetus by drugs
0.000 0.974 0.026
O35.4 Maternal care for (suspected) damage to foetus from alcohol
0.000 0.974 0.026
O35.3 Maternal care for (suspected) damage to foetus from viral disease in mother
0.000 0.974 0.026
O35.2 Maternal care for (suspected) hereditary disease in foetus
0.000 0.974 0.026
O35.0 Maternal care for (suspected) central nervous system malformation in foetus
0.000 0.974 0.026
O36 Maternal care for other known or suspected foetal problems
0.000 0.975 0.025
O46.8 Other antepartum haemorrhage
0.000 0.975 0.025
O46.0 Antepartum haemorrhage with coagulation defect
0.000 0.975 0.025
M48.0 Spinal stenosis
0.025 0.975 0.000
M48.06 Spinal stenosis (Lumbar region)
0.024 0.976 0.000
O44.0 Placenta praevia specified as without haemorrhage
0.000 0.976 0.024
O44.1 Placenta praevia with haemorrhage
0.000 0.976 0.024
O30.0 Twin pregnancy
0.000 0.977 0.023
O30.9 Multiple gestation, unspecified
0.000 0.977 0.023
O30.8 Other multiple gestation
0.000 0.977 0.023
O30.2 Quadruplet pregnancy
0.000 0.977 0.023
O30.1 Triplet pregnancy
0.000 0.977 0.023
O31.8 Other complications specific to multiple gestation
0.000 0.977 0.023
O31.2 Continuing pregnancy after intra-uterine death of one foetus or more
0.000 0.977 0.023
O31.1 Continuing pregnancy after abortion of one foetus or more
0.000 0.977 0.023
O31.0 Papyraceous foetus
0.000 0.977 0.023
O33.9 Maternal care for disproportion, unspecified
0.000 0.977 0.023
O33.8 Maternal care for disproportion of other origin
0.000 0.977 0.023
O33.7 Maternal care for disproportion due to other foetal deformities
0.000 0.977 0.023
O33.6 Maternal care for disproportion due to hydrocephalic foetus
0.000 0.977 0.023
O33.5 Maternal care for disproportion due to unusually large foetus
0.000 0.977 0.023
O33.4 Maternal care for disproportion of mixed maternal and foetal origin
0.000 0.977 0.023
O33.3 Maternal care for disproportion due to outlet contraction of pelvis
0.000 0.977 0.023
O33.2 Maternal care for disproportion due to inlet contraction of pelvis
0.000 0.977 0.023
O33.1 Maternal care for disproportion due to generally contracted pelvis
0.000 0.977 0.023
O33.0 Maternal care for disproportion due to deformity of maternal pelvic bones
0.000 0.977 0.023
M48.02 Spinal stenosis (Cervical region)
0.023 0.977 0.000
O41.0 Oligohydramnios
0.000 0.978 0.022
O45.8 Other premature separation of placenta
0.000 0.978 0.022
O45.0 Premature separation of placenta with coagulation defect
0.000 0.978 0.022
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.022 0.978 0.000
M46.9 Inflammatory spondylopathy, unspecified
0.022 0.978 0.000
Y44 Agents primarily affecting blood constituents
0.021 0.979 0.000
O41.9 Disorder of amniotic fluid and membranes, unspecified
0.000 0.979 0.021
O41.1 Infection of amniotic sac and membranes
0.000 0.979 0.021
M48 Other spondylopathies
0.021 0.979 0.000
M48.09 Spinal stenosis (Site unspecified)
0.021 0.979 0.000
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)
0.021 0.979 0.000
O45.9 Premature separation of placenta, unspecified
0.000 0.980 0.020
M48.07 Spinal stenosis (Lumbosacral region)
0.020 0.980 0.000
Y44.2 Anticoagulants
0.020 0.980 0.000
O36.0 Maternal care for rhesus isoimmunisation
0.000 0.980 0.020
O04.9 Complete or unspecified, without complication
0.000 0.980 0.020
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)
0.020 0.980 0.000
M46 Other inflammatory spondylopathies
0.020 0.980 0.000
Chapter XV Pregnancy, childbirth and the puerperium
0.000 0.980 0.020
Y52 Agents primarily affecting the cardiovascular system
0.019 0.981 0.000
O04 Medical abortion
0.000 0.981 0.019
M45-M49 Spondylopathies
0.019 0.981 0.000
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)
0.019 0.981 0.000
Y44.5 Thrombolytic drugs
0.019 0.981 0.000
O36.4 Maternal care for intra-uterine death
0.000 0.981 0.019
O36.7 Maternal care for viable foetus in abdominal pregnancy
0.000 0.982 0.018
O36.2 Maternal care for hydrops foetalis
0.000 0.982 0.018
O36.1 Maternal care for other isoimmunisation
0.000 0.982 0.018
Y48 Anaesthetics and therapeutic gases
0.018 0.982 0.000
O20-O29 Other maternal disorders predominantly related to pregnancy
0.000 0.982 0.018
O00-O08 Pregnancy with abortive outcome
0.000 0.982 0.018
Y51 Drugs primarily affecting the autonomic nervous system
0.018 0.982 0.000
O48 Prolonged pregnancy
0.000 0.982 0.018
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)
0.018 0.982 0.000
M48.05 Spinal stenosis (Thoracolumbar region)
0.018 0.982 0.000
M48.04 Spinal stenosis (Thoracic region)
0.018 0.982 0.000
M48.03 Spinal stenosis (Cervicothoracic region)
0.018 0.982 0.000
M48.01 Spinal stenosis (Occipito-atlanto-axial region)
0.018 0.982 0.000
O36.9 Maternal care for foetal problem, unspecified
0.000 0.982 0.018
O36.8 Maternal care for other specified foetal problems
0.000 0.982 0.018
Chapter XX External causes of morbidity and mortality
0.018 0.982 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.018 0.982 0.000
O41.8 Other specified disorders of amniotic fluid and membranes
0.000 0.982 0.017
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.018 0.982 0.000
O20 Haemorrhage in early pregnancy
0.000 0.983 0.017
O20.9 Haemorrhage in early pregnancy, unspecified
0.000 0.983 0.017
Y43 Primarily systemic agents
0.017 0.983 0.000
M47 Spondylosis
0.017 0.983 0.000
O36.3 Maternal care for signs of foetal hypoxia
0.000 0.983 0.016
O36.5 Maternal care for poor foetal growth
0.000 0.983 0.016
O47.1 False labour at or after 37 completed weeks of gestation
0.000 0.983 0.016
M48.00 Spinal stenosis (Multiple sites in spine)
0.016 0.984 0.000
W20-W49 Exposure to inanimate mechanical forces
0.016 0.984 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.016 0.984 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.016 0.984 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.016 0.984 0.000
Y59 Other and unspecified vaccines and biological substances
0.016 0.984 0.000
Y58 Bacterial vaccines
0.016 0.984 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.016 0.984 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.016 0.984 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.016 0.984 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.016 0.984 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.016 0.984 0.000
Y57 Other and unspecified drugs and medicaments
0.016 0.984 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.016 0.984 0.000
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)
0.016 0.984 0.000
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)
0.016 0.984 0.000
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)
0.016 0.984 0.000
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)
0.016 0.984 0.000
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)
0.016 0.984 0.000
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)
0.016 0.984 0.000
V40-V49 Car occupant injured in transport accident
0.016 0.984 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.016 0.984 0.000
Y44.7 Plasma substitutes
0.016 0.984 0.000
Y44.6 Natural blood and blood products
0.016 0.984 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.016 0.984 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.016 0.984 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.016 0.984 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.016 0.984 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.016 0.984 0.000
O36.6 Maternal care for excessive foetal growth
0.000 0.984 0.015
Y48.4 Anaesthetic, unspecified
0.015 0.984 0.000
M48.9 Spondylopathy, unspecified
0.015 0.985 0.000
M48.8 Other specified spondylopathies
0.015 0.985 0.000
M48.4 Fatigue fracture of vertebra
0.015 0.985 0.000
M48.3 Traumatic spondylopathy
0.015 0.985 0.000
M48.2 Kissing spine
0.015 0.985 0.000
M48.1 Ankylosing hyperostosis [Forestier]
0.015 0.985 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.015 0.985 0.000
V01-V09 Pedestrian injured in transport accident
0.015 0.985 0.000
Y43.0 Antiallergic and antiemetic drugs
0.015 0.985 0.000
M47.9 Spondylosis, unspecified
0.015 0.985 0.000
O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium
0.000 0.985 0.015
O04.1 Incomplete, complicated by delayed or excessive haemorrhage
0.000 0.985 0.015
O21 Excessive vomiting in pregnancy
0.000 0.985 0.015
W25 Contact with sharp glass
0.015 0.985 0.000
Y52.1 Calcium-channel blockers
0.015 0.985 0.000
O26 Maternal care for other conditions predominantly related to pregnancy
0.000 0.985 0.014
Y48.2 Other and unspecified general anaesthetics
0.014 0.985 0.000
V10-V19 Pedal cyclist injured in transport accident
0.014 0.985 0.000
M46.8 Other specified inflammatory spondylopathies
0.014 0.986 0.000
M46.5 Other infective spondylopathies
0.014 0.986 0.000
M46.3 Infection of intervertebral disk (pyogenic)
0.014 0.986 0.000
M46.2 Osteomyelitis of vertebra
0.014 0.986 0.000
M46.1 Sacro-iliitis, not elsewhere classified
0.014 0.986 0.000
M46.0 Spinal enthesopathy
0.014 0.986 0.000
O85-O92 Complications predominantly related to the puerperium
0.000 0.986 0.014
X58-X59 Accidental exposure to other and unspecified factors
0.014 0.986 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.014 0.986 0.000
Y00-Y09 Assault
0.014 0.986 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.014 0.986 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.014 0.986 0.000
Y52.7 Peripheral vasodilators
0.014 0.986 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.014 0.986 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.014 0.986 0.000
O04.4 Incomplete, without complication
0.000 0.986 0.014
M48.5 Collapsed vertebra, not elsewhere classified
0.014 0.986 0.000
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)
0.014 0.986 0.000
O26.8 Other specified pregnancy-related conditions
0.000 0.986 0.014
Y54.4 Loop [high-ceiling] diuretics
0.014 0.986 0.000
O04.8 Complete or unspecified, with other and unspecified complications
0.000 0.986 0.014
O04.7 Complete or unspecified, complicated by embolism
0.000 0.986 0.014
O04.6 Complete or unspecified, complicated by delayed or excessive haemorrhage
0.000 0.986 0.014
O04.5 Complete or unspecified, complicated by genital tract and pelvic infection
0.000 0.986 0.014
O04.3 Incomplete, with other and unspecified complications
0.000 0.986 0.014
O04.2 Incomplete, complicated by embolism
0.000 0.986 0.014
O04.0 Incomplete, complicated by genital tract and pelvic infection
0.000 0.986 0.014
Y54.3 Benzothiadiazine derivatives
0.014 0.986 0.000
M49 Spondylopathies in diseases classified elsewhere
0.014 0.986 0.000
W25.9 Unspecified place
0.014 0.986 0.000
X10-X19 Contact with heat and hot substances
0.014 0.986 0.000
M47.96 Spondylosis, unspecified (Lumbar region)
0.014 0.986 0.000
W00-W19 Falls
0.014 0.986 0.000
O02 Other abnormal products of conception
0.000 0.986 0.014
M19.07 Primary arthrosis of other joints (Ankle and foot)
0.014 0.986 0.000
Y43.4 Immunosuppressive agents
0.014 0.986 0.000
M47.99 Spondylosis, unspecified (Site unspecified)
0.014 0.986 0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure
0.014 0.986 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.014 0.986 0.000
M46.4 Discitis, unspecified
0.013 0.986 0.000
Y60-Y69 Misadventures to patients during surgical and medical care
0.014 0.986 0.000
V04 Pedestrian injured in collision with heavy transport vehicle or bus
0.013 0.986 0.000
V49 Car occupant injured in other and unspecified transport accidents
0.013 0.986 0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use
0.013 0.986 0.000
Y48.5 Therapeutic gases
0.013 0.986 0.000
Y48.3 Local anaesthetics
0.013 0.986 0.000
Y48.1 Parenteral anaesthetics
0.013 0.986 0.000
Y48.0 Inhaled anaesthetics
0.013 0.986 0.000
X40-X49 Accidental poisoning by and exposure to noxious substances
0.013 0.987 0.000
O29 Complications of anaesthesia during pregnancy
0.000 0.987 0.013
O22 Venous complications in pregnancy
0.000 0.987 0.013
O25 Malnutrition in pregnancy
0.000 0.987 0.013
O08 Complications following abortion and ectopic and molar pregnancy
0.000 0.987 0.013
O07 Failed attempted abortion
0.000 0.987 0.013
O06 Unspecified abortion
0.000 0.987 0.013
O05 Other abortion
0.000 0.987 0.013
O01 Hydatidiform mole
0.000 0.987 0.013
W50-W64 Exposure to animate mechanical forces
0.013 0.987 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.013 0.987 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.013 0.987 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.013 0.987 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.013 0.987 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.013 0.987 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.013 0.987 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.013 0.987 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.013 0.987 0.000
Y51.0 Anticholinesterase agents
0.013 0.987 0.000
M47.8 Other spondylosis
0.013 0.987 0.000
W13 Fall from, out of or through building or structure
0.013 0.987 0.000
X50-X57 Overexertion, travel and privation
0.013 0.987 0.000
W21 Striking against or struck by sports equipment
0.013 0.987 0.000
Y35-Y36 Legal intervention and operations of war
0.013 0.987 0.000
Y10-Y34 Event of undetermined intent
0.013 0.987 0.000
X85-X99 Assault
0.013 0.987 0.000
X30-X39 Exposure to forces of nature
0.013 0.987 0.000
X00-X09 Exposure to smoke, fire and flames
0.013 0.987 0.000
W75-W84 Other accidental threats to breathing
0.013 0.987 0.000
W65-W74 Accidental drowning and submersion
0.013 0.987 0.000
V98-V99 Other and unspecified transport accidents
0.013 0.987 0.000
V95-V97 Air and space transport accidents
0.013 0.987 0.000
V90-V94 Water transport accidents
0.013 0.987 0.000
V70-V79 Bus occupant injured in transport accident
0.013 0.987 0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident
0.013 0.987 0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident
0.013 0.987 0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident
0.013 0.987 0.000
W13.9 Unspecified place
0.013 0.987 0.000
Y54.9 Mineral salts, not elsewhere classified
0.013 0.987 0.000
Y54.8 Agents affecting uric acid metabolism
0.013 0.987 0.000
Y54.7 Agents affecting calcification
0.013 0.987 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.013 0.987 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.013 0.987 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.013 0.987 0.000
Y54.0 Mineralocorticoids
0.013 0.987 0.000
W22 Striking against or struck by other objects
0.013 0.987 0.000
V20-V29 Motorcycle rider injured in transport accident
0.013 0.987 0.000
M47.1 Other spondylosis with myelopathy
0.013 0.987 0.000
O23 Infections of genito-urinary tract in pregnancy
0.000 0.987 0.013
V48 Car occupant injured in noncollision transport accident
0.013 0.987 0.000
Y43.9 Primarily systemic agent, unspecified
0.012 0.987 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.012 0.987 0.000
Y43.6 Enzymes, not elsewhere classified
0.012 0.987 0.000
Y43.5 Acidifying and alkalising agents
0.012 0.987 0.000
Y43.2 Antineoplastic natural products
0.012 0.987 0.000
Y43.1 Antineoplastic antimetabolites
0.012 0.987 0.000
Y54.5 Other diuretics
0.012 0.987 0.000
X20-X29 Contact with venomous animals and plants
0.012 0.987 0.000
O20.8 Other haemorrhage in early pregnancy
0.000 0.987 0.012
V04.1 Traffic accident
0.012 0.988 0.000
Y46.4 Iminostilbenes
0.012 0.988 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.012 0.988 0.000
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria
0.000 0.988 0.012
Y45.8 Other analgesics and antipyretics
0.012 0.988 0.000
M47.0 Anterior spinal and vertebral artery compression syndromes
0.012 0.988 0.000
O21.0 Mild hyperemesis gravidarum
0.000 0.988 0.012
V11 Pedal cyclist injured in collision with other pedal cycle
0.012 0.988 0.000
O28 Abnormal findings on antenatal screening of mother
0.000 0.988 0.012
V80-V89 Other land transport accidents
0.012 0.988 0.000
O16 Unspecified maternal hypertension
0.000 0.988 0.012
O20.0 Threatened abortion
0.000 0.988 0.012
V49.9 Car occupant [any] injured in unspecified traffic accident
0.012 0.988 0.000
Y46.8 Antispasticity drugs
0.012 0.988 0.000
Y46.7 Anti-Parkinsonism drugs
0.012 0.988 0.000
Y46.6 Other and unspecified antiepileptics
0.012 0.988 0.000
Y46.5 Valproic acid
0.012 0.988 0.000
Y46.3 Deoxybarbiturates
0.012 0.988 0.000
Y46.2 Hydantoin derivatives
0.012 0.988 0.000
Y46.1 Oxazolidinediones
0.012 0.988 0.000
Y46.0 Succinimides
0.012 0.988 0.000
W46 Contact with hypodermic needle
0.012 0.988 0.000
W45 Foreign body or object entering through skin
0.012 0.988 0.000
W43 Exposure to vibration
0.012 0.988 0.000
W42 Exposure to noise
0.012 0.988 0.000
W41 Exposure to high-pressure jet
0.012 0.988 0.000
W40 Explosion of other materials
0.012 0.988 0.000
W39 Discharge of firework
0.012 0.988 0.000
W38 Explosion and rupture of other specified pressurised devices
0.012 0.988 0.000
W37 Explosion and rupture of pressurised tyre, pipe or hose
0.012 0.988 0.000
W36 Explosion and rupture of gas cylinder
0.012 0.988 0.000
W35 Explosion and rupture of boiler
0.012 0.988 0.000
W34 Discharge from other and unspecified firearms
0.012 0.988 0.000
W33 Rifle, shotgun and larger firearm discharge
0.012 0.988 0.000
W32 Handgun discharge
0.012 0.988 0.000
W31 Contact with other and unspecified machinery
0.012 0.988 0.000
W30 Contact with agricultural machinery
0.012 0.988 0.000
W28 Contact with powered lawn mower
0.012 0.988 0.000
W27 Contact with nonpowered hand tool
0.012 0.988 0.000
W26 Contact with knife, sword or dagger
0.012 0.988 0.000
W24 Contact with lifting and transmission devices, not elsewhere classified
0.012 0.988 0.000
W23 Caught, crushed, jammed or pinched in or between objects
0.012 0.988 0.000
O24 Diabetes mellitus in pregnancy
0.000 0.988 0.012
W44 Foreign body entering into or through eye or natural orifice
0.012 0.988 0.000
W20 Struck by thrown, projected or falling object
0.012 0.988 0.000
M47.2 Other spondylosis with radiculopathy
0.012 0.988 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.012 0.988 0.000
Y45.5 4-Aminophenol derivatives
0.012 0.988 0.000
Y45.4 Antirheumatics
0.012 0.988 0.000
W08 Fall involving other furniture
0.012 0.988 0.000
Y57.9 Drug or medicament, unspecified
0.012 0.988 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.012 0.988 0.000
X59 Exposure to unspecified factor
0.012 0.988 0.000
Y04 Assault by bodily force
0.012 0.988 0.000
W49 Exposure to other and unspecified inanimate mechanical forces
0.012 0.988 0.000
Y45.0 Opioids and related analgesics
0.012 0.988 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.011 0.988 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.011 0.988 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.011 0.988 0.000
Y47.4 Bromine compounds
0.011 0.988 0.000
Y47.3 Paraldehyde
0.011 0.988 0.000
Y47.2 Chloral derivatives
0.011 0.988 0.000
Y47.1 Benzodiazepines
0.011 0.988 0.000
Y47.0 Barbiturates, not elsewhere classified
0.011 0.988 0.000
Y50.9 Central nervous system stimulant, unspecified
0.011 0.988 0.000
Y50.8 Other central nervous system stimulants
0.011 0.988 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.011 0.988 0.000
Y50.1 Opioid receptor antagonists
0.011 0.988 0.000
Y50.0 Analeptics
0.011 0.988 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.011 0.988 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.011 0.988 0.000
Y53.7 Emetics
0.011 0.988 0.000
Y53.6 Antidiarrhoeal drugs
0.011 0.988 0.000
Y53.5 Digestants
0.011 0.988 0.000
Y53.4 Other laxatives
0.011 0.988 0.000
Y53.3 Saline and osmotic laxatives
0.011 0.988 0.000
Y53.2 Stimulant laxatives
0.011 0.988 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.011 0.988 0.000
Y53.0 Histamine H2-receptor antagonists
0.011 0.988 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.011 0.988 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.011 0.988 0.000
Y55.5 Anticommon cold drugs
0.011 0.988 0.000
Y55.4 Expectorants
0.011 0.988 0.000
Y55.3 Antitussives
0.011 0.988 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.011 0.988 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.011 0.988 0.000
Y55.0 Oxytocic drugs
0.011 0.988 0.000
Y56.9 Topical agent, unspecified
0.011 0.988 0.000
Y56.8 Other topical agents
0.011 0.988 0.000
Y56.7 Dental drugs, topically applied
0.011 0.988 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.011 0.988 0.000
Y56.5 Ophthalmological drugs and preparations
0.011 0.988 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.011 0.988 0.000
Y56.3 Emollients, demulcents and protectants
0.011 0.988 0.000
Y56.2 Local astringents and local detergents
0.011 0.988 0.000
Y56.1 Antipruritics
0.011 0.988 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.011 0.988 0.000
Y58.9 Other and unspecified bacterial vaccines
0.011 0.988 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.011 0.988 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.011 0.988 0.000
Y58.5 Diphtheria vaccine
0.011 0.988 0.000
Y58.4 Tetanus vaccine
0.011 0.988 0.000
Y58.3 Plague vaccine
0.011 0.988 0.000
Y58.2 Cholera vaccine
0.011 0.988 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.011 0.988 0.000
Y58.0 BCG vaccine
0.011 0.988 0.000
Y59.9 Vaccine or biological substance, unspecified
0.011 0.988 0.000
Y59.8 Other specified vaccines and biological substances
0.011 0.988 0.000
Y59.3 Immunoglobulin
0.011 0.988 0.000
Y59.2 Protozoal vaccines
0.011 0.988 0.000
Y59.1 Rickettsial vaccines
0.011 0.988 0.000
Y59.0 Viral vaccines
0.011 0.988 0.000
Y49.9 Psychotropic drug, unspecified
0.011 0.988 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.011 0.988 0.000
Y49.7 Psychostimulants with abuse potential
0.011 0.988 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.011 0.988 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.011 0.988 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.011 0.988 0.000
Y49.2 Other and unspecified antidepressants
0.011 0.988 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.011 0.988 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.011 0.988 0.000
Y57.8 Other drugs and medicaments
0.011 0.988 0.000
Y57.7 Vitamins, not elsewhere classified
0.011 0.988 0.000
Y57.6 Other diagnostic agents
0.011 0.988 0.000
Y57.4 Pharmaceutical excipients
0.011 0.988 0.000
Y57.3 Alcohol deterrents
0.011 0.988 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.011 0.988 0.000
Y57.1 Lipotropic drugs
0.011 0.988 0.000
Y57.0 Appetite depressants [anorectics]
0.011 0.988 0.000
Y49.5 Other antipsychotics and neuroleptics
0.011 0.988 0.000
V47 Car occupant injured in collision with fixed or stationary object
0.011 0.988 0.000
V46 Car occupant injured in collision with other nonmotor vehicle
0.011 0.988 0.000
V45 Car occupant injured in collision with railway train or railway vehicle
0.011 0.988 0.000
V44 Car occupant injured in collision with heavy transport vehicle or bus
0.011 0.988 0.000
V43 Car occupant injured in collision with car, pick-up truck or van
0.011 0.988 0.000
V42 Car occupant injured in collision with two- or three-wheeled motor vehicle
0.011 0.988 0.000
V41 Car occupant injured in collision with pedal cycle
0.011 0.988 0.000
V40 Car occupant injured in collision with pedestrian or animal
0.011 0.988 0.000
Y45.2 Propionic acid derivatives
0.011 0.988 0.000
Y45.1 Salicylates
0.011 0.988 0.000
W29 Contact with other powered hand tools and household machinery
0.011 0.988 0.000
O00 Ectopic pregnancy
0.000 0.989 0.011
Y42.7 Androgens and anabolic congeners
0.011 0.989 0.000
M48.19 Ankylosing hyperostosis [Forestier] (Site unspecified)
0.011 0.989 0.000
M48.18 Ankylosing hyperostosis [Forestier] (Sacral and sacrococcygeal region)
0.011 0.989 0.000
M48.17 Ankylosing hyperostosis [Forestier] (Lumbosacral region)
0.011 0.989 0.000
M48.16 Ankylosing hyperostosis [Forestier] (Lumbar region)
0.011 0.989 0.000
M48.15 Ankylosing hyperostosis [Forestier] (Thoracolumbar region)
0.011 0.989 0.000
M48.14 Ankylosing hyperostosis [Forestier] (Thoracic region)
0.011 0.989 0.000
M48.13 Ankylosing hyperostosis [Forestier] (Cervicothoracic region)
0.011 0.989 0.000
M48.12 Ankylosing hyperostosis [Forestier] (Cervical region)
0.011 0.989 0.000
M48.11 Ankylosing hyperostosis [Forestier] (Occipito-atlanto-axial region)
0.011 0.989 0.000
M48.10 Ankylosing hyperostosis [Forestier] (Multiple sites in spine)
0.011 0.989 0.000
M48.29 Kissing spine (Site unspecified)
0.011 0.989 0.000
M48.28 Kissing spine (Sacral and sacrococcygeal region)
0.011 0.989 0.000
M48.27 Kissing spine (Lumbosacral region)
0.011 0.989 0.000
M48.26 Kissing spine (Lumbar region)
0.011 0.989 0.000
M48.25 Kissing spine (Thoracolumbar region)
0.011 0.989 0.000
M48.24 Kissing spine (Thoracic region)
0.011 0.989 0.000
M48.23 Kissing spine (Cervicothoracic region)
0.011 0.989 0.000
M48.22 Kissing spine (Cervical region)
0.011 0.989 0.000
M48.21 Kissing spine (Occipito-atlanto-axial region)
0.011 0.989 0.000
M48.20 Kissing spine (Multiple sites in spine)
0.011 0.989 0.000
M48.39 Traumatic spondylopathy (Site unspecified)
0.011 0.989 0.000
M48.38 Traumatic spondylopathy (Sacral and sacrococcygeal region)
0.011 0.989 0.000
M48.37 Traumatic spondylopathy (Lumbosacral region)
0.011 0.989 0.000
M48.36 Traumatic spondylopathy (Lumbar region)
0.011 0.989 0.000
M48.35 Traumatic spondylopathy (Thoracolumbar region)
0.011 0.989 0.000
M48.34 Traumatic spondylopathy (Thoracic region)
0.011 0.989 0.000
M48.33 Traumatic spondylopathy (Cervicothoracic region)
0.011 0.989 0.000
M48.32 Traumatic spondylopathy (Cervical region)
0.011 0.989 0.000
M48.31 Traumatic spondylopathy (Occipito-atlanto-axial region)
0.011 0.989 0.000
M48.30 Traumatic spondylopathy (Multiple sites in spine)
0.011 0.989 0.000
M48.49 Fatigue fracture of vertebra (Site unspecified)
0.011 0.989 0.000
M48.48 Fatigue fracture of vertebra (Sacral and sacrococcygeal region)
0.011 0.989 0.000
M48.47 Fatigue fracture of vertebra (Lumbosacral region)
0.011 0.989 0.000
M48.46 Fatigue fracture of vertebra (Lumbar region)
0.011 0.989 0.000
M48.45 Fatigue fracture of vertebra (Thoracolumbar region)
0.011 0.989 0.000
M48.44 Fatigue fracture of vertebra (Thoracic region)
0.011 0.989 0.000
M48.43 Fatigue fracture of vertebra (Cervicothoracic region)
0.011 0.989 0.000
M48.42 Fatigue fracture of vertebra (Cervical region)
0.011 0.989 0.000
M48.41 Fatigue fracture of vertebra (Occipito-atlanto-axial region)
0.011 0.989 0.000
M48.40 Fatigue fracture of vertebra (Multiple sites in spine)
0.011 0.989 0.000
M48.89 Other specified spondylopathies (Site unspecified)
0.011 0.989 0.000
M48.88 Other specified spondylopathies (Sacral and sacrococcygeal region)
0.011 0.989 0.000
M48.87 Other specified spondylopathies (Lumbosacral region)
0.011 0.989 0.000
M48.86 Other specified spondylopathies (Lumbar region)
0.011 0.989 0.000
M48.85 Other specified spondylopathies (Thoracolumbar region)
0.011 0.989 0.000
M48.84 Other specified spondylopathies (Thoracic region)
0.011 0.989 0.000
M48.83 Other specified spondylopathies (Cervicothoracic region)
0.011 0.989 0.000
M48.82 Other specified spondylopathies (Cervical region)
0.011 0.989 0.000
M48.81 Other specified spondylopathies (Occipito-atlanto-axial region)
0.011 0.989 0.000
M48.80 Other specified spondylopathies (Multiple sites in spine)
0.011 0.989 0.000
M48.99 Spondylopathy, unspecified (Site unspecified)
0.011 0.989 0.000
M48.98 Spondylopathy, unspecified (Sacral and sacrococcygeal region)
0.011 0.989 0.000
M48.97 Spondylopathy, unspecified (Lumbosacral region)
0.011 0.989 0.000
M48.96 Spondylopathy, unspecified (Lumbar region)
0.011 0.989 0.000
M48.95 Spondylopathy, unspecified (Thoracolumbar region)
0.011 0.989 0.000
M48.94 Spondylopathy, unspecified (Thoracic region)
0.011 0.989 0.000
M48.93 Spondylopathy, unspecified (Cervicothoracic region)
0.011 0.989 0.000
M48.92 Spondylopathy, unspecified (Cervical region)
0.011 0.989 0.000
M48.91 Spondylopathy, unspecified (Occipito-atlanto-axial region)
0.011 0.989 0.000
M48.90 Spondylopathy, unspecified (Multiple sites in spine)
0.011 0.989 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.011 0.989 0.000
Y41.5 Antiviral drugs
0.011 0.989 0.000
Y41.4 Anthelminthics
0.011 0.989 0.000
Y41.3 Other antiprotozoal drugs
0.011 0.989 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.011 0.989 0.000
Y41.1 Antimycobacterial drugs
0.011 0.989 0.000
Y41.0 Sulphonamides
0.011 0.989 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.